Trials / Recruiting
RecruitingNCT07298083
DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical research study is to learn if a handheld Mass Spectrometry device (MasSpec Pen) can accurately distinguish between masses, neurofibroma, and normal tissue during surgery.
Detailed description
Primary Objectives: Aim 1. Determine the metabolite and lipid profiles of MPNST, neurofibroma, and nerve tissues Aim 2. Validate the handheld mass spectrometry device (MSPen-Orbitrap system) for MPNST and neurofibroma diagnosis and for intraoperative surgical margin evaluation
Conditions
Timeline
- Start date
- 2026-04-02
- Primary completion
- 2030-04-30
- Completion
- 2032-04-20
- First posted
- 2025-12-23
- Last updated
- 2026-04-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07298083. Inclusion in this directory is not an endorsement.